IsoPlexis Webinars

See how industry pioneers are revealing the true immune biology at each development stage

All
  • All
  • Single-Cell Webinars
  • Technology Webinars
Single-Cell Webinars

Learn how discovery in cell therapy and combination therapy is benefiting from single-cell polyfunctional strength metrics

Identify the presence of small polyfunctional cell subpopulations that correlate with anti-tumor activities

Evaluate molecules that enhance the efficiency of cell therapy

Assess the effects of gene editing (CRISPR) on response in model systems

Single-Cell Polyfunctional Strength Applied to Cell Engineering & Therapy Discovery
Jon Chen, MS, Director, New Collaborators
Single-Cell Webinars

Discover biomarkers that could elucidate the mechanism of various autoimmune disorders as well as autoimmune and inflammatory reactions to immunotherapies

Explore IsoPlexis’ advanced immune-based approaches in systemic lupus erythematosus and adverse events like cytokine release syndrome and neurotoxicity in cell therapy

Determine correlates and drivers of adverse reactions using single-cell functional proteomics

Learn how these biomarkers may improve therapeutic development and intervention

Novel Single-Cell Biomarker Strategies for Autoimmune Disease and Adverse Events in Immunotherapy
Dr. Rong Fan, Yale University
Single-Cell Webinars

Uncover strategies to improve T-cell function in the TME, and Polyfunctional Strength Index (PSI) concerning a range of TME immunotherapy challenges

Improve T-cell functionality for adoptive T cell therapy in metastatic colon cancer using small-molecule strategies

Use PSI to Unlock key insights into how the immune system can be modulated to improve development and solid tumor immunotherapeutic strategies

Discover novel correlative single-cell data from T-cells from the blood of colon cancer patients

Improving T-cell Function in the Solid Tumor Microenvironment using Advanced Immunotherapeutic Strategies
Dr. Sruthi Ravindranathan, Post Doctoral Researcher in the Waller Lab at Winship Cancer Institute of Emory University
Single-Cell Webinars

Explore an overview of current biomarker strategies for guiding the use of combination checkpoint immunotherapies in blood cancers

Review advanced immune-based approaches in acute myeloid leukemia that combine chemotherapy with checkpoint therapy

Explore relevant biomarker strategies associated with these approaches

See how single-cell cytokine analysis system and PSI demonstrate that specific cytokine potency contributors correlate with overall survival

Biomarker Strategies for Optimizing Checkpoint Immunotherapy Treatment
Dr. Naval Daver, Associate Professor, Department of Leukemia, MD Anderson Cancer Center
Technology Webinars

Discover how to navigate IsoSpeak’s powerful visualizations of the single-cell data you need to correlate with outcomes

Access a unique collection of predeveloped tools to see the data at multiple levels

Adjust all views in real time based on user input

Explore complex single-cell datasets with novel, customized analytics

Streamline reporting with publication quality graphs and data exporting

Getting started with IsoSpeak Single-Cell Software: Advanced Visualizations to Enable Insights
Patrick Paczkowski, PhD, VP of Software, IsoPlexis
Technology Webinars

Walk through how the IsoLight system automates single cell data generation for analysis and visualization in IsoSpeak

Load prepared samples into preconfigured assay chips

Walk away chip processing, including cell separation, incubation, cell imaging and proteomic scanning

Parallel data generation for up to 8 samples per run

Export raw data merged with chip configuration info directly for data processing in IsoSpeak software

Getting started with the IsoLight System: How it works to automate your workflow and get you data
Peter Tsiompilkas, MS, VP or Product R&D, IsoPlexis
Technology Webinars

Learn how the sample preparation protocols simplify the process of getting the most out of every sample

Access a portfolio of predeveloped and validated protocols for enrichment and stimulation

Reduce development time and precious sample usage needed to get going

Customize protocols moving forward by tapping into IsoPlexis' assay development resources

Getting started with Sample Preparation on the IsoLight System: CAR-T project example
Jens Eberlein, PhD, Senior Field Application Scientist, IsoPlexis
Single-Cell Webinars

Discover how polyfunctional strength is making an impact with bispecifics and combination checkpoint therapies

Evaluate T cell responses induced by various bispecific T cell engagers across phenotypes

Understand the heterogeneity of TIL polyfunctionality in solid tumors in response to checkpoint inhibitors

Uniquely correlate clinical anti-tumor responses with IsoPlexis data

Optimize combination cancer vaccines in melanoma using model systems

Single-Cell Polyfunctional Strength Applied to Checkpoint & Antibody Based on Immunotherapies
Will Singleterry, PhD, Director of Business Development, IsoPlexis
Single-Cell Webinars

Understand how new innate & myeloid single cell functional profiling is uncovering drivers of inflammatory disease

Discover the impact of therapy on MS by tracking inflammatory polyfunctionality in monocytes

Uncover NK contribution to Crohn's disease through proinflammatory polyfunctionality

Reveal the striking heterogeneity of polyfunctionality in PMF patient granulocytes suggesting directions for therapy in MPNA

Single-Cell Polyfunctional Strength Applied to Innate & Myeloid Research
Jens Eberlein, PhD, Senior Field Application Scientist, IsoPlexis
Single-Cell Webinars

Discover the evolution of the cell therapy industry and how IsoPlexis is redefining what's possible through the ability to stratify patient response to novel immunotherapy regimens

Explore how cytokines reveal function in immunotherapy and the challenges in revealing mechanism & responders through blood cytokines & phenotype

Reveal highly polyfunctional immune cells that correlate to in-vivo response to immunotherapy

Uncover potent cytokine mechanism using Single-Cell PSI to reveal responders in trials with checkpoint inhibitors

Better by Design: Single-Cell Characterization for Enhanced Cell Therapies
Dr. James Heath, Professor and President of the Institute of System Biology